-
Palliative Care Pays OffPatients with advanced cancer who receive palliative care tend to live longer and have better quality of life than those who do not receive this care.
by Cheryl Platzman Weinstock
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Why I Put Down My CameraA professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer.
by Jay Perry
-
A Sense of PurposeIn a Facebook Live discussion about When Breath Becomes Air, Lucy Kalanithi talks about safeguarding a person’s identity in the face of terminal disease and shares tips and resources for caregiving.
by Marci A. Landsmann
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
New Tactics for Bladder CancerAfter decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Raising Their VoicesPeople with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Forward Look
Drug Combo Targets Polyp GrowthStudy findings support precision approaches to risk reduction.
by Dara Chadwick
-
Caregiving With Confidence
Make Your Mental Health a PriorityRecognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
